Lower Plasma Soluble Transferrin Receptor Range in Healthy Indian Pediatric Cohort as Compared to Asian and Western

P Bhatia1, D Siyaram1, Deepshikha1

  • 1Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012 India.

Insights

This study establishes normal soluble transferrin receptor levels in healthy children aged 2-12 years. The findings reveal lower levels than previously reported, highlighting the need for age-specific reference ranges in pediatric diagnostics.

Area of Science:

  • Biochemistry
  • Hematology
  • Pediatrics

Background:

  • Soluble serum transferrin receptor (sTfR) reflects iron-dependent erythropoiesis.
  • Adult sTfR levels range from 2-5 mg/l, with pediatric ranges reported lower (1.0-3.0 mg/l).

Purpose of the Study:

  • To establish normal soluble transferrin receptor (sTfR) reference ranges in healthy children aged 2-12 years.
  • To address the scarcity of pediatric sTfR data.

Main Methods:

  • Evaluation of 40 healthy children (2-12 years).
  • Detection of sTfR levels using sensitive ELISA methodology.

Main Results:

  • Mean sTfR levels in the study cohort were 0.39 mg/l (range: 0.17-2.1 mg/l).
  • These levels were significantly lower compared to previously reported mean values (4.39 mg/l in Western studies, 2.0 mg/l in national studies).

Conclusions:

  • There is a critical need to establish population-specific and age-specific normal ranges for sTfR.
  • Standardized testing and reporting methods are essential for accurate interpretation of pediatric sTfR levels in clinical diagnostics.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
375
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
286